23
The particle size is measured according to the provisions of the EN13544-1:2007 “Respiratory therapy
EQUIPMENT 0ART .EBULIZING SYSTEMS AND THEIR COMPONENTSv !NNEX ## USING THE MULTISTAGE
cascade impactor method.
0ARTICLE 3IZE
*MMAD 4.2 μm
MMAD = Mass Median Aerodynamic Diameter
-EDICATION #ONTAINER #APACITY
ML MAXIMUM
3OUND
Less than 20 dB
.EBULIZATION RATE
**Greater than 0.25 ml/min (by weight loss)
!EROSOL /UTPUT
*0.69 ml (2ml, 1%NaF)
!EROSOL /UTPUT 2ATE
*0.087 ml/min (2ml, 1%NaF)
.OTES
s 4HE DISTRIBUTION OF PARTICLE SIZE AND AEROSOL OUTPUT ARE MEASURED WITH .A& SOLUTION 4HE PARTICLE SIZE
distribution and aerosol output may vary by combination of product, medication and ambient conditions such
as temperature, humidity and atmospheric pressure.
s 0ERFORMANCE MAY VARY WITH DRUGS SUCH AS SUSPENSIONS OR HIGH VISCOSITY 3EE DRUG SUPPLIERS DATA SHEET FOR
further details.
s 3EE WEB SITE OF /-2/. (%!,4(#!2% %52/0% TO UPDATE TECHNICAL INFORMATION
URL: www.omron-healthcare.com
* Independently measured at SolAero Ltd., Canada, Dr. John Dennis, according to EN13544-1:2007.
** The Nebulization rate is measured with saline 0.9% solution at 23°C and can vary with medication and
ambient conditions.
Cumulative % particle mass of sodium fluoride under size
0
10
20
30
40
50
60
70
80
90
100
0010111.0
Particle Size Dp (μm)
Cumulative Undersize %
Individual
Mean
MMAD 4.2 μm
4ECHNICAL DATA
To Next Page
Loading...
